NASDAQ:NKBP - China Nuokang Bio-Pharmaceutical Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $5.54 0.00 (0.00 %) (As of 10/16/2018 04:00 PM ET)Previous Close$5.54Today's RangeN/A52-Week RangeN/AVolumeN/AAverage VolumeN/AMarket Capitalization$108.95 millionP/E RatioN/ADividend YieldN/ABetaN/A Company ProfileDiscussionChartEarnings HistoryFinancialsHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email China Nuokang Bio-Pharmaceutical Inc. is a biopharmaceutical company focused on research, development, manufacture, marketing and sales of hospital-based medical products. As of December 31, 2010, it sold a portfolio of 15 products, including four principal products: Baquting, its bleeding control product; Kaitong, its lipid emulsion alprostadil product for the treatment of peripheral vascular diseases, cardiocerebral microcirculation disorders and post-surgery thrombosis; Aiduo, its cardiovascular stress imaging agent, and Aiwen, its anti-arrhythmic agent. Its product pipeline includes three product candidates under development for bleeding control and hematological, cardiovascular and cerebrovascular disease diagnosis, treatment and prevention. In February 2013, it announced the completion of the merger with Kingbird Mergerco. Inc., a wholly owned subsidiary of Kingbird Investment Inc. As a result of the merger the Company became a wholly owned subsidiary of Kingbird Investment Inc. Receive NKBP News and Ratings via Email Sign-up to receive the latest news and ratings for NKBP and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry N/A Sub-IndustryN/A SectorN/A SymbolNASDAQ:NKBP CUSIPN/A Webwww.nkbp.com Phone+86-24-24696033 Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / CashN/A Book ValueN/A Price / BookN/A Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/A Miscellaneous EmployeesN/A Outstanding SharesN/AMarket Cap$108.95 million China Nuokang Bio-Pharmaceutical (NASDAQ:NKBP) Frequently Asked Questions What is China Nuokang Bio-Pharmaceutical's stock symbol? China Nuokang Bio-Pharmaceutical trades on the NASDAQ under the ticker symbol "NKBP." How do I buy shares of China Nuokang Bio-Pharmaceutical? Shares of NKBP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is China Nuokang Bio-Pharmaceutical's stock price today? One share of NKBP stock can currently be purchased for approximately $5.54. How big of a company is China Nuokang Bio-Pharmaceutical? China Nuokang Bio-Pharmaceutical has a market capitalization of $108.95 million. What is China Nuokang Bio-Pharmaceutical's official website? The official website for China Nuokang Bio-Pharmaceutical is http://www.nkbp.com/. How can I contact China Nuokang Bio-Pharmaceutical? China Nuokang Bio-Pharmaceutical's mailing address is No. 18-1 East Nanping Road Hunnan Natnl New & High-tch Dvlpmnt Zone, SHENYANG, LIA 110171, China. The biopharmaceutical company can be reached via phone at +86-24-24696033. MarketBeat Community Rating for China Nuokang Bio-Pharmaceutical (NASDAQ NKBP)Community Ranking: 2.9 out of 5 ( )Outperform Votes: 53 (Vote Outperform)Underperform Votes: 38 (Vote Underperform)Total Votes: 91MarketBeat's community ratings are surveys of what our community members think about China Nuokang Bio-Pharmaceutical and other stocks. Vote "Outperform" if you believe NKBP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NKBP will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 10/16/2018 by MarketBeat.com StaffFeatured Article: What is intrinsic value?